Related Experiment Video
Updated: Mar 14, 2026

An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins
Published on: June 26, 2018
New insights into synaptic vesicle dysfunction in Parkinson's disease.
Julita Chlebowicz1, Violetta Ivanova1, Jacqueline Burré1
1Brain and Mind Research Institute, Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY 10021, USA.
Synaptic vesicle (SV) dysfunction is a key factor in Parkinson's disease (PD) pathology, affecting neurotransmitter transport and release. Targeting these early synaptic changes offers a promising therapeutic avenue for PD.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Parkinson's disease (PD) involves progressive motor and non-motor symptoms.
- Synaptic pathology, preceding neuronal loss, is central to PD pathogenesis.
- PD-linked genes regulate synaptic vesicle (SV) trafficking, indicating SV dysfunction's role.
Purpose of the Study:
- To review how SV dysfunction contributes to PD pathology.
- To examine the effects of disease-linked proteins on the SV cycle.
- To explore the impact of synaptic pathology on brain function and potential therapies.
Main Methods:
- Literature review of recent studies on SV dysfunction in PD.
- Analysis of how PD-linked proteins affect SV trafficking and the SV cycle.
- Examination of presynaptic pathology's effects on postsynaptic plasticity and circuits.
Main Results:
- Three critical pathogenic mechanisms identified: impaired neurotransmitter import/storage, disrupted SV pool organization, and altered SV exocytosis/endocytosis.
- Presynaptic pathology triggers impairments in postsynaptic plasticity.
- Circuit-level reorganization occurs across brain regions due to synaptic dysfunction.
Conclusions:
- Presynaptic SV dysfunction is a central mechanism in PD pathogenesis.
- Understanding these synaptic changes is crucial for developing PD therapies.
- Targeting early synaptic alterations presents a promising therapeutic strategy for Parkinson's disease.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Lysosomal Hydrolases
Neural Regulation
Fusion of Secretory Vesicles with the Plasma Membrane
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
Postsynaptic Potential (PSP)
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...

